Combined association of general and central obesity with incidence and mortality of cancers in 22 sites

Parra Soto, S. L., Petermann-Rocha, F., Boonpor, J., Gray, S. R. , Pell, J. P. , Celis-Morales, C. and Ho, F. K. (2020) Combined association of general and central obesity with incidence and mortality of cancers in 22 sites. American Journal of Clinical Nutrition, (doi: 10.1093/ajcn/nqaa335) (PMID:33381801) (Early Online Publication)

[img] Text
225758.pdf - Accepted Version
Restricted to Repository staff only until 31 December 2021.

708kB

Abstract

Background Body mass index (BMI) and waist circumference (WC) are measures of general and central obesity, respectively, and both have been shown to be associated with cancer. However, there is insufficient evidence of their combined association with the risk of cancer. Objectives This study aimed to investigate the associations of combinations of BMI and WC with cancer at 22 sites. Methods A total of 386,101 (54.5% women) UK Biobank participants aged from 37 to 73 y were included. The outcomes were incidence of and mortality from cancer at 22 sites. Participants were categorized as normal weight (BMI 18.5–24.9) or overweight (including obese, BMI ≥ 25) and as normal WC or centrally obese (WC ≥ 94 cm for men and ≥80 cm for women). Four mutually exclusive groups were derived: 1) normal weight without central obesity, 2) normal weight with central obesity, 3) overweight without central obesity, and 4) overweight with central obesity. We used Cox proportional hazards models to estimate HRs and 95% CIs. Results The mean follow-up period was 8.8 y. Compared with participants with normal weight and WC, men who were overweight and centrally obese had higher cancer incidence risk at 3 sites [stomach (HR: 1.75; 95% CI: 1.33, 2.32; Padj = 0.002), kidney (HR: 1.45; 95% CI: 1.17, 1.81; Padj = 0.016), and colorectal (HR: 1.31; 95% CI: 1.17, 1.47; Padj < 0.001) cancer]. Similar associations were found at 4 sites in women [endometrial (HR: 2.48; 95% CI: 2.06, 2.98; Padj < 0.001), uterine (HR: 2.23; 95% CI: 1.89, 2.64; Padj < 0.001), kidney (HR: 1.84; 95% CI: 1.37, 2.46; Padj = 0.001), and breast (HR: 1.24; 95% CI: 1.16, 1.32; Padj < 0.001) cancer] and for all-cause cancer (HR: 1.07; 95% CI: 1.03, 1.10; Padj = 0.003). Only endometrial cancer mortality (HR: 3.28; 95% CI: 1.77, 6.07; Padj = 0.004) was significantly associated with being overweight and centrally obese. Conclusions The combination of general and central obesity was associated with a higher risk at several cancer sites and some associations were sex-specific.

Item Type:Articles
Additional Information:Funding: SPS and FPR were funded by the Chilean Government PhD scholarship program JB were funded by the Thai Government PhD scholarship program. No other funding’s have been received for conducting this study.
Status:Early Online Publication
Refereed:Yes
Glasgow Author(s) Enlighten ID:Celis, Dr Carlos and Pell, Professor Jill and Gray, Dr Stuart and Ho, Dr Frederick and Petermann, Mrs Fanny and Parra Soto, Solange Liliana and Boonpor, Jirapitcha
Authors: Parra Soto, S. L., Petermann-Rocha, F., Boonpor, J., Gray, S. R., Pell, J. P., Celis-Morales, C., and Ho, F. K.
College/School:College of Medical Veterinary and Life Sciences > Institute of Cardiovascular and Medical Sciences
College of Medical Veterinary and Life Sciences > Institute of Health and Wellbeing > Public Health
Journal Name:American Journal of Clinical Nutrition
Publisher:Oxford University Press
ISSN:0002-9165
ISSN (Online):1938-3207
Published Online:31 December 2020

University Staff: Request a correction | Enlighten Editors: Update this record